[Comment] Antibody-based malaria prevention in an intense perennial transmission setting

Despite substantial progress in malaria control over the past two decades, malaria caused by Plasmodium falciparum remains a leading cause of morbidity and mortality in sub-Saharan Africa, particularly in young children.1 Achievement of malaria elimination will require complementary interventions that target different stages of the parasite lifecycle and can be implemented in different transmission settings.2 In addition to vector control, chemoprevention, and vaccination, monoclonal antibodies targeting parasite antigens have emerged as a promising strategy for malaria prevention.